DIAN-TU Trial Results: Biomarkers, The Power of CSF

Description: An overview of the use of biomarkers in cerebrospinal fluid to track Alzheimer’s disease progression and measure the effectiveness of drugs to treat Alzheimer’s disease
Runtime: 00:17:13

Speaker: Anne M. Fagan, MD
Speaker title: Biomarker Core Leader
Speaker organization: Washington University in St. Louis

Event: 2020 Virtual DIAD Family Conference
Year: 2020

Search tags: biomarkers, clinical trials, cerebrospinal fluid, CSF, research participation, amyloid plaques, tau tangles, neurodegeneration, blood-brain barrier, preclinical Alzheimer’s, gantenerumab, solanezumab, cognitive impairment, neuronal injury, CSF NfL, open-label extension, secondary prevention, primary prevention